It is still debated whether AML-derived angiogenesis, in terms of MVD in the BM and VEGF quantification, is reduced in patients upon chemotherapy (Aref et al., 2005, Chand et al., 2016, Padro et al., 2000, Reddy and Moreb, 2000). Here, VEGFA is linked to acute myeloid leukemia.